Compass Diversified Tapped Of Envista Holdings As Finance Chief, Taking Over From Ryan Faulkingham, Effective August 31
Compass Diversified Tapped Of Envista Holdings As Finance Chief, Taking Over From Ryan Faulkingham, Effective August 31
Compass Diversified (NYSE:CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to facilitate a seamless transition.
envista holdings（NYSE: CODI）（" CODI "或" 公司 "）是主要的中市場業務的所有者，宣佈斯蒂芬·凱勒（Stephen Keller）於2024年8月31日被任命爲公司首席財務官（CFO）。他將取代瑞安·福爾奇漢姆（Ryan Faulkingham），後者自2013年7月以來一直擔任該公司的CFO，並於2024年8月30日離開該公司。福爾奇漢將繼續以諮詢顧問的身份發揮作用，以實現無縫過渡。
In his new role, Mr. Keller will lead CODI's finance organization, including accounting, planning, treasury, tax, reporting, and investor relations. He brings to CODI over 25 years of executive finance experience across multiple industries, including automotive, healthcare, industrial, specialty materials, retail and apparel branding, and media.
在他的新職位上，凱勒先生將領導CODI的財務組織，包括會計、計劃、財務、稅務、報告和投資者關係。他在多個行業擁有超過25年的高管財務經驗，包括汽車、醫療保健、工業、特種材料、零售和服裝品牌以及媒體。
Most recently, Mr. Keller served as Interim Chief Financial Officer and Vice President of Investor Relations at Envista Holdings Corporation (NYSE:NVST), a $2.6 billion company and one of the leading suppliers of dental solutions globally. During his time at Envista, he also served as Vice President Strategy and Business Development, as well as Vice President and General Manager of Nobel Biocare's Prosthetics Business Unit.
凱勒先生最近曾擔任Envista Holdings Corporation（NYSE: NVST）的臨時財務總監兼投資者關係副總裁，該公司是一家26億美元的公司，也是全球領先的牙科解決方案供應商之一。在Envista擔任期間，他還擔任戰略和業務發展副總裁，以及Nobel Biocare的修復業務部門副總裁兼總經理。
